Company presentations
Molecular Partners
Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN) is a clinical-stage biotech company pioneering the design and development of a new class of custom-built protein drugs known as DARPin therapeutics.
The Company has programs in pre-clinical and clinical development and partnerships with leading pharmaceutical companies to bring innovative solutions to cancer patients.
Molecular Partners was founded in 2004 and has offices in both Zurich, Switzerland and Concord, MA, USA.
Date, time and room information
May 6, 16:15 - 16:30, room Montreal
Category
Clinical stage development company
Title of the presentation
Extending the Boundaries of Targeted Cancer Therapies: Radio-DARPins & Next-Gen Immune Cell Engagers
Speaker information
| Name | Position | Institution |
|---|---|---|
| Laura Jeanbart | Head of Portfolio Management & Communications |
